Report overview
This report aims to provide a comprehensive presentation of the global market for Human Microbiome Sequencing Instrument, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome Sequencing Instrument. This report contains market size and forecasts of Human Microbiome Sequencing Instrument in global, including the following market information:
Global Human Microbiome Sequencing Instrument Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Microbiome Sequencing Instrument Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Human Microbiome Sequencing Instrument companies in 2022 (%)
The global Human Microbiome Sequencing Instrument market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Reagents and Kits Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Microbiome Sequencing Instrument include Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S, Eurofins Scientific SE, GENEWIZ, Inc., Illumina, Inc., Novogene Corporation and OraSure Technologies, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Microbiome Sequencing Instrument manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Microbiome Sequencing Instrument Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Microbiome Sequencing Instrument Market Segment Percentages, by Type, 2022 (%)
Reagents and Kits
Instruments
Liquid Handling Instruments
Cytometers
Imaging Devices
Microplate Reader
Others
Global Human Microbiome Sequencing Instrument Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Microbiome Sequencing Instrument Market Segment Percentages, by Application, 2022 (%)
Research and Academic Institutions
Pharmaceutical and Biotechnology Companies
Hospital and Clinic
Others
Global Human Microbiome Sequencing Instrument Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Microbiome Sequencing Instrument Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Microbiome Sequencing Instrument revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Microbiome Sequencing Instrument revenues share in global market, 2022 (%)
Key companies Human Microbiome Sequencing Instrument sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Human Microbiome Sequencing Instrument sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baseclear B.V.
Beijing Genomics Institute (BGI) Genomics Co., Ltd
Charles River Laboratories International Inc.
Clinical Microbiomics A/S
Eurofins Scientific SE
GENEWIZ, Inc.
Illumina, Inc.
Novogene Corporation
OraSure Technologies, Inc.
Oxford Nanopore Technologies, Inc.
Pacific Biosciences of California, Inc.
QIAGEN N.V.
Second Genome, Inc.
Thermo Fisher Scientific Inc.
Viome, Inc.
CosmosID
Leucine Rich Bio Pvt. Ltd.
Microba
Microbiome Insights Inc.
Molzym GmbH & Co. KG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Microbiome Sequencing Instrument, market overview.
Chapter 2: Global Human Microbiome Sequencing Instrument market size in revenue and volume.
Chapter 3: Detailed analysis of Human Microbiome Sequencing Instrument manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Microbiome Sequencing Instrument in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Microbiome Sequencing Instrument capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
